Navigation Links
People With Higher IQs are More Patient in Financial Matters

A study by scientists at the University of Bonn and the Institute for the Study of Labour has revealed that intelligent people are more patient in financial matters.

In the study of 1000 adults in Germany, the researcher asked the respondents if someone gave them the choice of 100 euros today or 150 euros in a year's time, which sum would they take?

The researchers measured the cognitive abilities of the participants, using two different methods. The result was that intelligent people prefer to wait for a higher return, rather than going for the money now.

This is the first time that this relationship between intelligence and patience in financial matters has been shown. Furthermore, the willingness to run risks increases with higher intelligence.

Scientists gave the test subjects 100 euros. The participants could put this amount straight into their pockets. However, they could also invest it for a year at a guaranteed fixed rate of interest. In this way the 100 euros would become, for example, 105, 120 or 150 euros. In an experiment the candidates were supposed to decide what the minimum amount would have to be in a year's time for it to be worth waiting longer for.

"The more intelligent the test subjects were, the more patient and tolerant of risk they were," is how the Bonn Professor of Economics, Dr. Armin Falk, sums the results up.

In conjunction with his colleagues Dr. Thomas Dohmen, Dr. Uwe Sunde and Dr. David Huffman at the IZA, Professor Falk was able to prove that the link between patience and cognitive abilities is even valid if the income factor is taken into account.

"What's more, according to our analysis, other indirect factors of influence can be excluded as an explanation," Professor Falk emphasised.

Instead, intelligence, patience and risk tolerance seem to be closely interconnected -- and probably for a good reason. In order to be a
'"/>




Page: 1 2

Related medicine news :

1. Bad News for Short People
2. New hope on the Horizon for People Wishing to Quit Smoking
3. Prescription Drug - Helps People Stop Smoking
4. More People Seeking Treatment for Depression
5. Pain Common in People with MS
6. People with skin cancer at higher risk for other types
7. Laser Therapy Found To Help People Quit Smoking
8. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
9. New Treatment For People Allergic To Cats
10. People who fight wars may be at high risk of cardiovascular disease
11. People suffering from Alzheimer’s: can they take decisions about their treatment
Post Your Comments:
(Date:12/2/2008)... The Health Story Project was anno...formerly known as “Clinical Document Archite...CDA4CDT will continue as the label for the technic...d to Health Level Seven (HL7) for ballot. The new ...Wire EON) December 2, 2008 -- "Our group has...
(Date:12/2/2008)...OR, Mich.---Older people tend to feel about 13 yea...is one of the findings of a study forthcoming in t... . The researchers analyzed the responses of 516 m...the Berlin Aging Study, tracking how their percept...hanged over a six-year period. , "People general...
(Date:12/2/2008)...elease is available in French . , Deep venous... the lower limbs, is the third-most common vascula...stroke, and is a frequent complication in hospital...ion that can lead to rapid death from pulmonary em... health concern that the U.S. Surgeon General and ...
(Date:12/2/2008)... WASHINGTON, Dec. 2 ...l deliver the Keynote address at eHealth Initiativ... the Pulse of Health IT: A Critical Review of Prog...ons for 2009 and Beyond." , , (Logo: http:..., , The Keynote speech will begin at 4:30 p...
Breaking Medicine News(10 mins):Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5Health News:Old as you want to be: Study finds most seniors feel younger 2Health News:Thrombosis patients face greater risks than previously believed 2
... which is causing confusion among scientists, //...the scientist work overtime to decipher the reason...ive, queen bee, food and the young. Many years ag... leave the hive to be ransacked by honey bees from...
...could not seem to keep up with the other children ...hings compared to the other children. Her running ...ses it was found that she has CMT, Charcot-Marie-T...nd that her father and her brother Tony too suffer...
... tract infection. Wan et al reviewed //the clinica... and treatment. This study is important since urin...es of unexplained fevers in infants with an overal... 10%. All the patients in this study underwent ren...
...s interfere with the therapeutic effects of chemot...review of the use of antioxidants during chemother...s, tumor response, and the patient’s ability to to...mplications for patients whose oncologists discour...
Other Medicine News:Health News:Vanishing Honey Bees 2Health News:Cure for CMT 2Health News:Antioxidants May Aid Chemotherapy Patients 2
(Date:12/2/2008)...c. 2 Horizon Therapeutics, Inc., a...announced that two pivotal,Phase 3 trials evaluat...T-501,met all primary endpoints. HZT-501, a nove...taining ibuprofen and famotidine, demonstrated a,...ce of non-steroidal,anti-inflammatory drug (NSAID...
(Date:12/1/2008)... CHICAGO, Dec. 2 A stu...EM), a new technique for imaging the breast, is no...ormonal status, two factors that limit the effecti...g cancer. Results will be presented today at the a... America (RSNA). , , "The ability of PEM t...
(Date:12/1/2008)...1 S*BIO Pte Ltd today announced th...18, a potent and orally-active JAK2 inhibitor, in ...with chronic idiopathic myelofibrosis (CIMF). , ...ty and tolerability of SB1518 in patients with CIM... Phase 1 part of the study will assess the safety ...
(Date:12/1/2008)...hows the Prox1 gene is a two-way switch that, if t...e reprogrammed so that they lose their identity an..., MEMPHIS, Tenn., Dec. 1 /PRNewswire-USNewswire/...spital have discovered that a certain differentiat...at it requires the constant expression of a gene c...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 1JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 2JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 3Kowa Company Ltd Acquires ProEthic Pharmaceuticals Inc 6913 1Kowa Company Ltd Acquires ProEthic Pharmaceuticals Inc 6913 2Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 1Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 2Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 3Huifeng Bio Pharmaceutical 28HFGB 29 to Release Second Quarter 2008 Earnings Results on August 15 2008 6904 1
...ion during the,early post-operative period compare...ion in nausea in the female,patient population com... CeNeS Pharmaceuticals plc (AIM:,CEN), the Cambrid...tional data from post-hoc analysis of the recent P...nide) in over 500 patients,with post-operative pai...
...0%; mso-hyphenate: none">,BUDAPEST, Hungary, June,...sands of patients with cancer from suffering,unnec...ngress of,the European Association for Palliative ...ated whether this first in class novel,formulation...,duration of effect, mirroring the breakthrough pa...
Other Medicine Technology:Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6
Inquire
Inquire
...nce, the SZX7 is designed for ease of use and work...ns to advanced research. The SZX7 offers one of th...ding image clarity, true color and accurate reprod...ined detail. System modularity and abundant access...
A compact stereomicroscope that is immediately ready for operation and extremely easy to use. Focused on the essential performance features, the Stemi DV4 design concept provides optimum utility.
Medicine Products: